Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
BALLERUP, Denmark and HURLEY, England, July 27, 2017 /CNW/ - New top 50 list ranks LEO Pharma in second position, leading the global pharma industry in commitments to increase access to clinical...
BALLERUP, Denmark, June 15, 2017 /CNW/ - LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human...
BALLERUP, Denmark and ORLANDO, FL, March 3, 2017 /CNW/ - LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with...
BALLERUP, Denmark, July 1, 2016 /CNW/ - LEO Pharma is a significant step closer to realising its vision of becoming the preferred dermatology care partner following a strategic partnership with...
BALLERUP, Denmark, March 21, 2016 /CNW/ - The marketing approval of Enstilar® would make it the first fixed combination topical foam treatment for people living with psoriasis vulgaris in the EU. LEO ...
BALLERUP, Denmark, Nov. 11, 2015 /CNW/ - LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today...
BALLERUP, Denmark, June 10, 2015 /CNW/ - LEO Pharma A/S today announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar®...
/NOT FOR US MEDIA/ The digital press release with multimedia content can be accessed here: http://www.multivu.com/players/uk/7276254-WCCS-Picato-actinickeratosis/ BALLERUP, Denmark, Sept. 4, 2014...
Two-three day treatment provides clinically relevant, sustained clearance of AK after 12 months BALLERUP, Denmark, March 20, 2013 /CNW/ - An analysis of long-term clearance rates of actinic keratosis ...
BALLERUP, Denmark, March 19, 2013 /CNW/ - LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation (NPF) in the United States that puts patients at the heart of LEO...
MENLO PARK, California and BALLERUP, Denmark, March 18, 2013 /CNW/ - Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development of an oral treatment for psoriasis...
BALLERUP, Denmark and PLANEGG-MARTINSRIED, Germany, Feb. 26, 2013 /CNW/ - LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into an exclusive research and...
BALLERUP, Denmark, Nov. 19, 2012 /CNW/ - Today LEO Pharma announced that the European Commission (EC) has granted marketing authorisation for Picato® (ingenol mebutate) gel as a treatment for actinic ...
BALLERUP, Denmark, Oct. 3, 2012 /CNW/ - LEO Pharma has announced plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The ambitious...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.